BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37457667)

  • 1. Linear energy transfer-inclusive models of brainstem necrosis following proton therapy of paediatric ependymoma.
    Handeland AH; Indelicato DJ; Fredrik Fjæra L; Ytre-Hauge KS; Pettersen HES; Muren LP; Lassen-Ramshad Y; Stokkevåg CH
    Phys Imaging Radiat Oncol; 2023 Jul; 27():100466. PubMed ID: 37457667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy.
    Fjæra LF; Indelicato DJ; Handeland AH; Ytre-Hauge KS; Lassen-Ramshad Y; Muren LP; Stokkevåg CH
    Radiother Oncol; 2022 Oct; 175():47-55. PubMed ID: 35917900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
    Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
    Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The experimental dose ranges influence the LET
    Rørvik E; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2019 Sep; 64(19):195001. PubMed ID: 31357190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
    Paganetti H
    Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical note: Investigation of dose and LET
    Yang Y; Rwigema JM; Vargas C; Yu NY; Keole SR; Wong WW; Schild SE; Bues M; Liu W; Shen J
    Med Phys; 2022 Dec; 49(12):7428-7437. PubMed ID: 36208196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
    Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
    Giantsoudi D; Adams J; MacDonald S; Paganetti H
    Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phenomenological biological dose model for proton therapy based on linear energy transfer spectra.
    Rørvik E; Thörnqvist S; Stokkevåg CH; Dahle TJ; Fjaera LF; Ytre-Hauge KS
    Med Phys; 2017 Jun; 44(6):2586-2594. PubMed ID: 28295379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.
    Peeler CR; Mirkovic D; Titt U; Blanchard P; Gunther JR; Mahajan A; Mohan R; Grosshans DR
    Radiother Oncol; 2016 Dec; 121(3):395-401. PubMed ID: 27863964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.
    Haas-Kogan D; Indelicato D; Paganetti H; Esiashvili N; Mahajan A; Yock T; Flampouri S; MacDonald S; Fouladi M; Stephen K; Kalapurakal J; Terezakis S; Kooy H; Grosshans D; Makrigiorgos M; Mishra K; Poussaint TY; Cohen K; Fitzgerald T; Gondi V; Liu A; Michalski J; Mirkovic D; Mohan R; Perkins S; Wong K; Vikram B; Buchsbaum J; Kun L
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):152-168. PubMed ID: 29619963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
    Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
    Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
    Grün R; Friedrich T; Traneus E; Scholz M
    Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the impact of alpha/beta and LET
    Mara E; Clausen M; Khachonkham S; Deycmar S; Pessy C; Dörr W; Kuess P; Georg D; Gruber S
    Med Phys; 2020 Aug; 47(8):3691-3702. PubMed ID: 32347564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.